GOSS Archived Articles
Gossamer Bio (GOSS): Unlocking the Potential of a Rare Disease Drug Pipeline
Published on March 14, 2025
Gossamer Bio, Inc. (NASDAQ:GOSS): A Promising Biopharmaceutical Play in the Fight Against Pulmonary Hypertension
Published on September 24, 2024